Alexforbes reports double-digit decline in half-year Heps
Pension funds administrator Alexforbes reported a double-digit decline in half-year headline earnings on Monday, as
Reports
Stealth BioTherapeutics Reports Fiscal Year 2020 Financial Results And Recent Business Highlights
BOSTON, April 6, 2021 /PRNewswire/ — Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused
Bolt Biotherapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
– Upsized IPO in February 2021 raised $264.5 million in gross proceeds plus Series C
BiomX Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
NESS ZIONA, Israel–(BUSINESS WIRE)–Mar 31, 2021– BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”),
AgeX Therapeutics Reports Fourth Quarter and Annual 2020 Financial Results and Provides Business Update
ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for
Frequency Therapeutics Supplies Enterprise Updates and Reports Fourth Quarter and Full Year 2020 Fiscal Results
WOBURN, Mass.–(Enterprise WIRE)–Mar 29, 2021– Frequency Therapeutics, Inc. (Nasdaq: FREQ), a medical-stage biotechnology organization concentrated
I-Mab Reports Financial Results for Full Year of 2020 and Provides Business Updates
18 significant clinical milestones achieved since the Company’s IPO in January 2020, with multiple important
Harmony Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Business Updates
WAKIX® (pitolisant) Total Revenue of $160 Million for Full-Year 2020; $56 Million for Fourth Quarter
Evolus Reports Fourth Quarter and Full Year 2020 Results and Provides Business Update
Q4 2020 Net Revenue $20.6 Million, Highest Net Revenue Quarter Since Launch of Jeuveau® Pro
Celyad Oncology Reports Full Year 2020 Financial Results and Recent Business Highlights
No safety concerns or evidence of Graft-versus-Host disease reported from first dose cohort of Phase
Sana Biotechnology Reports Fourth Quarter and 2020 Financial Results and Business Updates
Expects to present data at multiple scientific conferences in 2021 2020 year-end cash position of
Aligos Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
– Advanced ALG-010133 and ALG-000184 into the clinic – both expected to generate safety and
Newtek Business Services Corp. Reports Full Year 2020 Financial Results
BOCA RATON, Fla., March 22, 2021 (GLOBE NEWSWIRE) — Newtek Business Services Corp. (“Newtek” or
Accenture Reports Very Strong Second-Quarter Results and Raises Business Outlook for Fiscal 2021 | Associated Press
NEW YORK–(BUSINESS WIRE)–Mar 18, 2021– Accenture (NYSE: ACN) reported financial results for the second quarter
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Update
Established in vivo genome editing research collaboration and exclusive license agreement with Eli Lilly Reported
Legend Biotech Reports Fourth Quarter and Full Year 2020 Financial Results and Business Update
Legend received approximately $659.8 million in gross proceeds through share capital increases during 2020, including
Accenture Reports Very Strong Second-Quarter Results and Raises Business Outlook for Fiscal 2021 |
NEW YORK–(BUSINESS WIRE)–Mar 18, 2021– Accenture (NYSE: ACN) reported financial results for the second quarter
22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and …
Key Business and Financial Highlights 22nd Century has a tremendous global commercial opportunity in the